QGEN Qiagen Earnings and EPS analysis

?
Relative Growth: Rel. Growth: 67
Relative Strength: Rel. Strength: 39
Relative Valuation: Rel. Valuation: 71
Relative Profitability: Rel. Profitability: 94

EPS in 2025 (TTM): $1.7

Last Report Period Date: Jun 30, 2025

As of November this year, based on Qiagen's most recent financial report, the company's trailing twelve months EPS is $1.7. During 2024, QGEN reported a per-share earnings of $0.38, which shows a decline compared to the EPS of $1.5 recorded in 2023. Qiagen's EPS for the quarterly period ending on Jun 30, 2025 came in at $0.44.

QGEN earnings history

Historical annual and quarterly earnings per share (EPS) data for Qiagen
EPS (TTM)
$1.7
EPS Growth YoY (Quarterly)
153%
EPS (Quarterly)
$0.44
EPS Growth (Quarterly)
4.8%

The yearly earnings per share during 2024 was $0.38, a decline of 74.7% compared to $1.5 recorded in 2023. Over the quarter ending Jun 30, 2025, the earnings per share came in at $0.44, reflecting a 153% increase compared to the same quarter a year earlier. As of June 2025, the TTM EPS is $1.7. During 2023, the annual earnings per share was $1.5, representing a decrease of 19.4% compared to 2022.

QGEN EPS growth

Earnings per share growth rates over time
EPS Growth YoY (Quarterly)
153%
EPS growth YoY
-74.7%
EPS growth 3Y avg
-44.7%
EPS growth 5Y avg
N/A

Qiagen has recorded a growth in earnings per share of 153% in the past 12 months (YoY, quarterly). During the past three years, QGEN registered an average yearly EPS growth of -44.7%. Over the last decade, QGEN had an average annual earnings per share growth of -3.1%.

QGEN Earnings Waterfall

Breakdown of revenue, profit and net income for Qiagen

QGEN Earnings vs Peers

What are the earnings of QGEN compared to its peers
Stock name Price to Earnings EPS grwoth 1Y EPS grwoth 3Y EPS grwoth 5Y
QGEN Qiagen NV 25.91 -74.7% -44.7% N/A
HOLX Hologic Inc 30.55 81.1% -22.8% N/A
BDX Becton Dickinson & Co 32.07 18.3% -5.3% 8%
TMO Thermo Fisher Scientific Inc 32.74 6.8% -5.5% 12.4%
GE General Electric Co 40.36 -28.4% N/A N/A
TECH BIO-TECHNE Corp 127.53 -56.1% -35.2% -20.7%

All data is based on quarterly TTM periods, unless otherwise specified.